Skip to main content

Advertisement

Log in

Familial coexistence of demyelinating diseases and familial Mediterranean fever

  • Case Based Review
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

Familial Mediterranean fever (FMF) is a monogenic autoinflammatory disease characterized by fever and serositis attacks caused by mutations in the MEditerranean FeVer (MEFV) gene encoding the pyrin gene. Gain of the function mutations of the pyrin gene lead to stimulation of pro-inflammatory cytokines. Persistent pro-inflammatory situation in the course of FMF may play a role in the development of some other inflammatory diseases such as Behcet’s disease, psoriasis, and vasculitis. Multiple sclerosis (MS), as a demyelinating disorder, is also more commonly seen in FMF patients compared to the general population. There are scarcely any research reporting that these two diseases coexist in more than one person in the same family. We have discovered cases of FMF and demyelinating disorders in five members of two different families. Besides the two families we are reporting, there are only four other families reported so far. Having combined the data of all these six families, we present a case-based review in this study. We aimed to draw attention of physicians to familial co-occurence of FMF and demyelinating disorders and also to discuss possible mechanisms of the coexistence of these two diseases in light of the literature.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Sonmez HE, Batu ED, Ozen S (2016) Familial Mediterranean fever: current perspectives. J Inflamm Res 9:13–20

    CAS  PubMed  PubMed Central  Google Scholar 

  2. Park YH, Wood G, Kastner DL, Chae JJ (2016) Pyrininflammasome activation and RhoAsignaling in the autoinflammatory diseases FMF and HIDS. Nat Immunol 17:914–921

    Article  CAS  Google Scholar 

  3. Korkmaz C, Ozdogan H, Kasapçopur O, Yazici H (2002) Acute phase response in familial Mediterranean fever. Ann Rheum Dis 61:79–81

    Article  CAS  Google Scholar 

  4. Tunca M, Ozdogan H, Kasapcopur O, Yalcinkaya F, Tutar E, Topaloglu R et al (2005) Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study. Medicine 84:1–11

    Article  Google Scholar 

  5. Ozdogan H, Arisoy N, Kasapçapur O et al (1997) Vasculitis in familial Mediterranean fever. J Rheumatol 24:323–327

    CAS  PubMed  Google Scholar 

  6. Akar S, Soysal O, Balci A, Solmaz D, Gerdan V, Onen F et al (2013) High prevalence of spondyloarthritis and ankylosing spondylitis among familial Mediterranean fever patients and their first-degree relatives: further evidence for the connection. Arthritis Res Ther 28(15):R21

    Article  Google Scholar 

  7. Balcı-Peynircioğlu B, Kaya-Akça Ü, Arıcı ZS, Avcı E, Akkaya-Ulum ZY, Karadağ Ö et al (2020) Comorbidities in familial Mediterranean fever: analysis of 2000 genetically confirmed patients. Rheumatology (Oxford) 1(59):1372–1380

    Article  Google Scholar 

  8. Yildiz M, Adrovic A, Tasdemir E, Baba-Zada K, Aydin M, Koker O et al (2020) Evaluation of co-existing diseases in children with familial Mediterranean fever. RheumatolInt 40:57–64

    Article  CAS  Google Scholar 

  9. Marek-Yagel D, Berkun Y, Padeh S, Abu A, Reznik-Wolf H, Livneh A et al (2009) Clinical Disease among patients heterozygous for familial Mediterranean fever. Arthritis Rheum 60:1862–1866

    Article  CAS  Google Scholar 

  10. Akman-Demir G, Gül A, Gürol E, Özdoğan H, Bahar S et al (2006) Inflammatory/demyelinating central nervous system involvement in familial Mediterranean fever (FMF): coincidence or association? J Neurol 253:928–934

    Article  CAS  Google Scholar 

  11. Compston A, Coles A (2008) Multiple sclerosis. Lancet 372:1502–1517

    Article  CAS  Google Scholar 

  12. Kümpfel T, Gerdes LA, Wacker T, Blaschek A, Havla J, Krumbholz M et al (2012) Familial Mediterranean fever-associated mutation pyrin E148Q as a potential risk factor for multiple sclerosis. Mult Scler 18:1229–1238

    Article  Google Scholar 

  13. Livneh A, Langevitz P, Zemer D, Zaks N, Kees S, Lidar T, Migdal A et al (1997) Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 40:1879–1885

    Article  CAS  Google Scholar 

  14. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD et al (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol 50:121–127

    Article  CAS  Google Scholar 

  15. Yildirim ME, Kurtulgan HK, Ozdemir O, Kilicgun H, Aydemir DS, Baser B, Sezgin I (2019) Prevalence of MEFV gene mutations in a large cohort of patients with suspected familial Mediterranean fever in Central Anatolia. Ann Saudi Med 39:382–387

    Article  Google Scholar 

  16. Harirchian MH, Fatehi F, Sarraf P, Honarvar NM, Bitarafan S (2018) Worldwide prevalence of familial multiple sclerosis: a systematic review and meta-analysis. MultSclerRelatDisord 20:43–47

    Google Scholar 

  17. Unal A, Dursun A, Emre U, Tascilar NF, Ankarali H (2010) Evaluation of common mutations in the Mediterranean fever gene in multiple sclerosis patients: is it a susceptibility gene? J NeurolSci 294(1–2):38–42

    CAS  Google Scholar 

  18. Shinar Y, Livneh A, Villa Y, Pinhasov A, Zeitoun I, Kogan A, Achiron A (2003) Common mutations in the familial Mediterranean fever gene associate with rapid progression to disability in non-Ashkenazi Jewish multiple sclerosis patients. Genes Immun 4:197–203

    Article  CAS  Google Scholar 

  19. Chae JJ, Aksentijevich I, Kastner DL (2009) Advances in the understanding of familial Mediterranean fever and possibilities for targeted therapy. Br J Haematol 146:467Y478

    Article  Google Scholar 

  20. Hauser SL, Doolittle TH, Lincoln R, Brown RH, Dinarello CA (1990) Cytokine accumulations in CSF of multiple sclerosis patients: frequent detection of interleukin-1 and tumor necrosis factor but not interleukin-6. Neurology 40:1735–1739

    Article  CAS  Google Scholar 

  21. Ugurlu S, Ergezen B, Egeli BH, Selvi O, Ozdogan H (2020) Anakinra treatment in patients with familial Mediterranean fever: a single-centre experience. Rheumatol (Oxf) 9:596. https://doi.org/10.1093/rheumatology/keaa596 (Online ahead of print)

    Article  CAS  Google Scholar 

  22. de Jong BA, Huizinga TW, Bollen EL, Uitdehaag BM, Bosma GP, van Buchem MA et al (2002) Production of IL-1beta and IL-1Ra as risk factors for susceptibility and progression of relapse-onset multiple sclerosis. J Neuroimmunol 126(1–2):172–179

    Article  Google Scholar 

  23. Cree BAC (2014) Handbook of Clinical Neurology. In: Godin DS (ed) Multiple sclerosis genetics, 3rd edn. Elsevier, US San Francisco, pp 193–209

    Google Scholar 

  24. Mahfouz R, Kreidieh K, Khalek RA, Yazbek S (2017) Familial Mediterranean fever: observations from a pilot gene expression microarray analysis study. Cell MolBiol 63:26–28 (Noisy-le-grand)

    CAS  Google Scholar 

  25. Kinikli G, Bektas M, Mısırlıoğlu M, Ates A, Turgay M, Tuncer S et al (2005) Relationship between HLA-DR, HLA-DQ alleles and MEFV gene mutations in familial mediterranean fever (FMF) patients. Turk J Gastroenterol 16:143–146

    PubMed  Google Scholar 

  26. Ozen S, Demirkaya E, Erer B et al (2016) EULAR recommendations for the management of familial Mediterranean fever. Ann Rheum Dis 75:644–651

    Article  CAS  Google Scholar 

  27. Siegal S (1964) Familial paroxysmal polyserositis. Analysis of fifty cases. Am J Med 36:893–918

    Article  CAS  Google Scholar 

  28. Artemiadis AK, Anagnostouli MC, Alexopoulos EC (2011) Stress as a risk factor for multiple sclerosis onset or relapse: a systematic review. Neuroepidemiology 36:109–120

    Article  Google Scholar 

  29. Mohr DC, Hart SL, Julian L, Cox D, Pelletier D (2004) Association between stressful life events and exacerbation in multiple sclerosis: a meta-analysis. BMJ 328(7442):731

    Article  Google Scholar 

  30. Franklin GM, Nelson LM, Heaton RK, Burks JS, Thompson DS (1988) Stress and its relationship to acute exacerbations in multiple sclerosis. J NeurolRehabilit 2:7–11

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

Study Concepts and design: CK, DUC, SCK; analysis and interpretation of data: CK, DUC, SCK; drafting of the manuscript: CK, DUC, SCK; critically revision of the manuscript for important intellectual content: CK, DUC, SCK; final approval of the version to be published: CK, DUC, SCK.

Corresponding author

Correspondence to Cengiz Korkmaz.

Ethics declarations

Informed consent

Written informed consent was obtained from all patients for publication of this case-based review.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Korkmaz, C., Üsküdar Cansu, D. & Kabay, S.C. Familial coexistence of demyelinating diseases and familial Mediterranean fever. Rheumatol Int 42, 167–173 (2022). https://doi.org/10.1007/s00296-021-04821-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-021-04821-7

Keywords

Navigation